Romiplostim
Romiplostim in Children With Immune Thrombocytopenia: A Phase 3, Randomised, Double-Blind, Placebo-Controlled Study
A Randomized, Double-Blind Study of Romiplostim to Determine Its Safety and Efficacy in Children With Immune Thrombocytopenia